OtherArticle
Differential enantiomer-specific signaling of cannabidiol at CB1 receptors
Taryn Bosquez, Sierra Wilson, Christos Iliopoulos-Tsoutsouvas, Shan Jiang, Jim Wager-Miller, Spyros P. Nikas, Ken P. Mackie, Alexandros Makriyannis and Alex Straiker
Molecular Pharmacology September 24, 2022, MOLPHARM-AR-2021-000305; DOI: https://doi.org/10.1124/molpharm.121.000305
Taryn Bosquez
1Department of Neuroscience, Indiana University-Bloomington, United States
Sierra Wilson
2Indiana University-Bloomington, United States
Christos Iliopoulos-Tsoutsouvas
3Northeastern University, United States
Shan Jiang
3Northeastern University, United States
Jim Wager-Miller
2Indiana University-Bloomington, United States
Spyros P. Nikas
3Northeastern University, United States
Ken P. Mackie
4Gill Center, IU, United States
Alexandros Makriyannis
5Center for Drug Discovery, Northeastern University, United States
Alex Straiker
6Indiana Univ, United States
Jump to comment:
No eLetters have been published for this article.
In this issue
Molecular Pharmacology
Vol. 105, Issue 4
1 Apr 2024
OtherArticle
CBD enantiomer signaling
Taryn Bosquez, Sierra Wilson, Christos Iliopoulos-Tsoutsouvas, Shan Jiang, Jim Wager-Miller, Spyros P. Nikas, Ken P. Mackie, Alexandros Makriyannis and Alex Straiker
Molecular Pharmacology September 24, 2022, MOLPHARM-AR-2021-000305; DOI: https://doi.org/10.1124/molpharm.121.000305
OtherArticle
CBD enantiomer signaling
Taryn Bosquez, Sierra Wilson, Christos Iliopoulos-Tsoutsouvas, Shan Jiang, Jim Wager-Miller, Spyros P. Nikas, Ken P. Mackie, Alexandros Makriyannis and Alex Straiker
Molecular Pharmacology September 24, 2022, MOLPHARM-AR-2021-000305; DOI: https://doi.org/10.1124/molpharm.121.000305
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement